The
global resuscitation devices market is anticipated to grow at a rate of 4.8% from
USD 7.5 Billion in 2021 to USD 10.9 billion in 2029. The rise in the grants by the government for
providing Emergency care infrastructure and the growing incidence of preterm births
in many developing countries is seen to boost the market for the estimated
forecast period. Besides, the harmful effects of certain Resuscitation Devices on a newborn are seen to
hinder the growth of Resuscitation Devices.
Resuscitation devices refer to the devices that are used in emergencies
and help in the process of reviving the patient’s breath or to initiate
spontaneous breathing at an unconscious stage or apparent death by using the
positive pressure to inflate the lungs, therefore, keeping the patient
oxygenated. These devices comprise various devices such as resuscitation masks,
ventilators, resuscitation trolleys, resuscitation suction and mechanical
pumps, resuscitation pediatric spacer, and others.
In addition to this, efforts made by the major players to develop novel
resuscitation devices, online customer services for resuscitation devices are
also expected to fuel the growth of this market. Moreover, untapped potential
in developing countries is likely to create lucrative opportunities for the
market. However, the harmful effects of certain products on neonates, issues
associated with the use of automated external defibrillators, and lack of
awareness about sudden cardiac arrest in emerging nations may restrain the
growth of this market. The challenge faced by this market is the stringent
regulations set by the government bodies for medical devices.
COVID-19
Impact on Global Resuscitation Devices Market
Resuscitation
is a challenging task for any healthcare professional. The rise in the number
of COVID-19 cases across the globe had an inclination for rapid respiratory
failure leading to the involvement of different critical care admission and
resuscitative treatment. During the Pandemic there was a rise in cardiac
arrest due to severe COVID-19 disease, thus leading to a substantial increase
in the overall demand for the Resuscitation Devices market.
Market
Segmentation
For the
purpose of this report, the global resuscitation devices market is segmented on
the basis of product type, patient type, end-user and region:
Product Type Outlook (Revenue, USD Million;
2018-2029)
|
Airway Management Devices
|
Ventilators
|
ICU Ventilators
|
|
|
Portable Ventilators
|
|
|
|
|
Endotracheal Tubes
|
|
|
Resuscitators
|
|
|
Tracheostomy Tubes
|
|
|
Laryngeal Mask Airways
|
|
|
Laryngoscopes
|
|
|
Nasopharyngeal Airways
|
|
|
Oropharyngeal Airways
|
|
External Defibrillators
|
Semi-Automated External Defibrillators
|
|
|
Fully Automated External Defibrillators
|
|
|
Wearable Cardioverter Defibrillators
|
|
Connective Warming Blankets
|
|
|
Other Resuscitation Devices
|
|
|
|
|
|
Patient Type Outlook (Revenue, USD Million;
2018-2029)
|
Adult Patients
|
Pediatric Patients
|
|
|
|
End User Outlook (Revenue, USD Million;
2018-2029)
|
Hospitals, Ambulatory Surgical Centers, and
Cardiac Centers
|
Pre-Hospital Care Settings
|
Other End Users
|
Product
Type Scenario:
On the basis of Product
Type, the market is segmented into Airway Management Devices, External
Defibrillators, Other Resuscitation Devices. Further, Airway Management Devices
is segmented into Ventilators, Endotracheal Tubes, Resuscitators, Tracheostomy
Tubes, Laryngeal Mask Airways, Laryngoscopes, Nasopharyngeal Airways,
Oropharyngeal Airways. Further, External Defibrillators are segmented into
Semi-Automated External Defibrillators, Fully Automated External
Defibrillators, Wearable Cardioverter Defibrillators.
Figure
1 - Resuscitation Devices Market, By Product Type (Market Size and Forecast by
Value - USD Million, 2021 & 2029)

Patient
Type Scenario:
On the basis of Patient
Type, the market is segmented into Adult Patients, Pediatric Patients.
Figure
2 - Resuscitation Devices Market, By Product Type (Market Size and Forecast by
Value - USD Million, 2021 & 2029)

End
User Scenario:
On the basis of End
User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and
Cardiac Centers, Pre-Hospital Care Settings, Other End Users.
Figure 3 - Resuscitation
Devices Market, By Product Type (Market Size and Forecast by Value - USD
Million, 2021 & 2029)

Regional
Scenario:
North America dominated
the market with a revenue of USD 3.8 million in 2019 due to the increased
demand for Resuscitation Devices. Increasing Number of New Product Approvals
and High Adoption Rate of Aeds in the Country to Boost Market Growth. Besides, Rising
Incidence of Target Diseases to Drive Market Growth in Canada.
The Asia Pacific is
expected to be substantial growth as a result of changing scenarios of the
healthcare sector. Increasing Presence of Global Market Players to Improve the
Availability of Advanced Resuscitation Devices in India. Moreover, Rising
Prevalence of Target Diseases to Drive Market Growth in China.
Figure
4 - Resuscitation Devices Market: Regional dynamics

Regional Outlook
(Revenue, USD million; 2018-2029)
|
North America
|
U.S.
|
|
Canada
|
Europe
|
Germany
|
|
U.K.
|
|
France
|
|
Spain
|
|
Italy
|
|
Rest of the Europe
|
Asia Pacific
|
India
|
|
Japan
|
|
China
|
|
South Korea
|
|
Australia
|
|
Rest of Asia-Pacific
|
Middle East & Africa
|
UAE
|
|
Saudi Arabia
|
|
South Africa
|
|
Rest of Middle East & Africa
|
Latin America
|
Brazil
|
|
Mexico
|
|
Argentina
|
|
Rest of Latin America
|
Companies
Considered And Profiled In This Market Study
The
players operating in the market have undertaken several strategies related to
the market in the period 2019-2021. The key highlight is:
Koninklijke Philips
N.V., Medtronic Plc, Zoll Medical (A Part of Asahi Kasei), Physio-Control (A
Part of Stryker Corporation), Drägerwerk Ag & Co. KGaA, Cardinal Health,
Smiths Medical (A Division of Smiths Group Plc), Mindray Medical, Nihon Kohden,
Teleflex, and others have been profiled in the report. They are significant market players.
The players operating in the market have
undertaken several strategies related to the market in the period 2018-2021.
The key highlight is:
· On June 2021, ZOLL Medical Corporation announced
an agreement with Global Healthcare SG, a developer of portable body cooling
solutions, distributing the Carbon Cool Full Body Suit and Comfort Suit in
Asia-Pacific countries.
· On April 2021, ZOLL Medical Corporation, announced the acquisition of
Respicardia, Inc., a provider of novel implantable neurostimulators for the
treatment of moderate to severe Central Sleep Apnea (CSA). CSA is a serious
condition that is often associated with heart failure, coronary artery disease,
and certain cardiac arrhythmias.
Segments Covered in the report
This report forecasts revenue growth at a
global, regional & country level, and provides an analysis of the market
trends in each of the sub-segments from 2018 to 2029. The scope of the report can
be defined as:
Historical data
|
2018 - 2020
|
Base year for estimation
|
2021
|
Forecast period
|
2022 - 2029
|
Market size value in 2022
|
USD XX Billion
|
Revenue forecast in 2029
|
USD 4.22 Billion
|
Growth Rate
|
CAGR of 4.8% from 2022 to 2029
|
Quantitative units
|
Revenue in USD
million/billion & CAGR from 2022 to 2029
|
Report coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
Segments covered
|
Product Type, Patient
Type, End User, Region
|
Regional Scope
|
North America, Europe, Asia Pacific, Middle East & Africa,
Latin America
|
Country Scope
|
U.S., Canada,
Germany, U.K., France, Italy, Spain, India, Japan, China, Australia, South
Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina
|
Key companies profiled
|
Koninklijke Philips N.V., Medtronic Plc, Zoll Medical (A Part of
Asahi Kasei), Physio-Control (A Part of Stryker Corporation), Drägerwerk Ag
& Co. KGaA, Cardinal Health, Smiths Medical (A Division of Smiths Group
Plc), Mindray Medical, Nihon Kohden, Teleflex
|
Customization scope
|
Free report
customization (equivalent to up to 8 analysts’ working days) with purchase.
Addition or alteration to country, regional & segment scope.
|
Table of Content
Chapter 1. Introduction
1.1.
Market
Definition
1.2.
Research
Scope
1.2.1.
Markets
Covered
1.2.2.
Years
Considered for Study
Chapter 2. Research
Methodology
2.1.
Research
Sources
2.1.1.
Primary
2.1.2.
Secondary
2.2.
Market
Size Estimation
Chapter 3. Executive
Summary
3.1.
Summary
Snapshot Market Size and Forecast, 2018-2029
3.2.
Resuscitation
Devices Market Share by Product Type, 2021 vs 2029 (USD Million)
3.3.
Resuscitation
Devices Market Share by Patient Type, 2021 vs 2029 (USD Million)
3.4.
Resuscitation
Devices Market Share by End User, 2021 vs 2029 (USD Million)
3.5.
Resuscitation
Devices Market Share by Region, 2021 vs 2029 (USD Million)
Chapter 4. Key
Insights
Chapter 5. Resuscitation
devices Segmentation & Impact Analysis
5.1.
Resuscitation
Devices Market Indicators Analysis
5.1.1. Market Drivers Analysis
5.1.1.1. Growing
Focus on Providing Public-Access Defibrillators and Rising Awareness Programs
on Their Use
5.1.1.2. Growth
in Investments, Funds, and Grants by Government Bodies for Improving Emergency
Care Infrastructure
5.1.1.3. High
Demand for Emergency Care
5.1.1.4. High
Incidence of Preterm Births
5.1.1.5. Rising
Prevalence of Target Diseases
5.1.2. Market Restraints Analysis
5.1.2.1. Harmful
Effects of Certain Products on Neonates
5.1.2.2. Issues
Related to the Use of Automated External Defibrillators
5.1.2.3. Lack
of Awareness About Sudden Cardiac Arrest in Developing Nations
5.1.3. Market Opportunity Analysis
5.1.3.1. Consolidated
market structure presents significant challenges for new entrants in atopices
dermatitis market.
5.1.3.2. Underdeveloped
healthcare infrastructure is hampering the market growth in developing
countries.
5.2.
Regulatory
Analysis
5.2.1. North America
5.2.1.1. U.S.
5.2.1.2. Canada
5.2.2. Europe
5.2.3. Asia Pacific
5.2.3.1. India
5.2.3.2. Japan
5.2.3.3. China
5.3.
Technological
Insights
5.4.
COVID-19
Impact analysis on Resuscitation Devices Market
5.5.
Porter’s
Five Forces Analysis
5.5.1.
Bargaining
Power of Buyers/Consumers
5.5.2.
Bargaining
Power of Suppliers
5.5.3.
Threat
of New Entrants
5.5.4.
Threat
of Substitute Products
5.5.5.
Intensity
of Competitive Rivalry
5.6.
Competitive
Metric Space Analysis
Chapter 6. Resuscitation
Devices Market, By Product Type (Market Size and Forecast by Value - USD Million,
2018 - 2029)
6.1.
Resuscitation
Devices Market, By Product Type (Market Size and Forecast by Value - USD
Million, 2018 - 2029)
6.1.1.
Airway
Management Devices
6.1.1.1. Ventilators
6.1.1.1.1.
ICU Ventilators
6.1.1.1.2.
Portable Ventilators
6.1.1.2. Endotracheal
Tubes
6.1.1.3. Resuscitators
6.1.1.4. Tracheostomy
Tubes
6.1.1.5. Laryngeal
Mask Airways
6.1.1.6. Laryngoscopes
6.1.1.7. Nasopharyngeal
Airways
6.1.1.8. Oropharyngeal
Airways
6.1.2.
External
Defibrillators
6.1.2.1. Semi-Automated
External Defibrillators
6.1.2.2. Fully
Automated External Defibrillators
6.1.2.3. Wearable
Cardioverter Defibrillators
6.1.3.
Connective
Warming Blankets
6.1.4.
Other
Resuscitation Devices
Chapter 7. Resuscitation
Devices Market, By Patient Type (Market Size and Forecast by Value - USD Million,
2018 - 2027)
7.1. Resuscitation Devices Mode of Administration Dynamics
& Market Share, 2019 & 2027
7.1.1.
Adult
Patients
7.1.2.
Pediatric
Patients
Chapter 8. Resuscitation
Devices Market, By Product Type (Market Size and Forecast by Value - USD Million,
2018 - 2027)
8.1. Resuscitation Devices Market End-Use Dynamics &
Market Share, 2019 & 2027
8.1.1.
Hospitals,
Ambulatory Surgical Centers, and Cardiac Centers
8.1.2.
Pre-Hospital
Care Settings
8.1.3.
Other
End Users
Chapter 9. Resuscitation
Devices Market, By Product Type (Market Size and Forecast by Value - USD Million,
2018 - 2027)
9.1. Resuscitation Devices Market Regional Dynamics
& Market Share, 2019 & 2027
9.2.
North America
9.2.1.
North
America Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.2.2.
North
America Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.2.3.
North
America Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.2.4.
North
America Resuscitation Devices Market, By Country, 2018-2029 (USD Million)
9.2.5. US
9.2.5.1. U.S.
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.2.5.2. U.S.
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.2.5.3. U.S.
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.2.6. Canada
9.2.6.1. Canada
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.2.6.2. Canada
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.2.6.3. Canada
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.3.
Europe
9.3.1.
Europe
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.3.2.
Europe
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.3.3.
Europe
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.3.4.
Europe
Resuscitation Devices Market, By Country, 2018-2029 (USD Million)
9.3.5. Germany
9.3.5.1. Germany
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.3.5.2. Germany
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.3.5.3. Germany
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.3.6. U.K.
9.3.6.1. U.K.
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.3.6.2. U.K.
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.3.6.3. U.K.
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.3.7. France
9.3.7.1. France
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.3.7.2. France
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.3.7.3. France
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.3.8. Spain
9.3.8.1. Spain
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.3.8.2. Spain
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.3.8.3. Spain
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.3.9. Italy
9.3.9.1. Italy
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.3.9.2. Italy
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.3.9.3. Italy
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.3.10. Rest of Europe
9.3.10.1. Rest
of Europe Resuscitation Devices Market, By Product Type, 2018-2029 (USD
Million)
9.3.10.2. Rest
of Europe Resuscitation Devices Market, By Patient Type, 2018-2029 (USD
Million)
9.3.10.3. Rest
of Europe Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.4.
Asia Pacific
9.4.1.
Asia
Pacific Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.4.2.
Asia
Pacific Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.4.3.
Asia
Pacific Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.4.4.
Asia
Pacific Resuscitation Devices Market, By Country, 2018-2029 (USD Million)
9.4.5. India
9.4.5.1. India
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.4.5.2. India
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.4.5.3. India
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.4.6. Japan
9.4.6.1. Japan
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.4.6.2. Japan
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.4.6.3. Japan
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.4.7. China
9.4.7.1. China
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.4.7.2. China
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.4.7.3. China
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.4.8. South Korea
9.4.8.1. South
Korea Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.4.8.2. South
Korea Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.4.8.3. South
Korea Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.4.9. Australia
9.4.9.1. Australia
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.4.9.2. Australia
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.4.9.3. Australia
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.4.10. Rest of Asia Pacific
9.4.10.1. Rest
of Asia Pacific Resuscitation Devices Market, By Product Type, 2018-2029 (USD
Million)
9.4.10.2. Rest
of Asia Pacific Resuscitation Devices Market, By Patient Type, 2018-2029 (USD
Million)
9.4.10.3. Rest
of Asia Pacific Resuscitation Devices Market, By End User, 2018-2029 (USD
Million)
9.5. Middle East & Africa
9.5.1.
Middle
East & Africa Resuscitation Devices Market, By Product Type, 2018-2029 (USD
Million)
9.5.2.
Middle
East & Africa Resuscitation Devices Market, By Patient Type, 2018-2029 (USD
Million)
9.5.3.
Middle
East & Africa Resuscitation Devices Market, By End User, 2018-2029 (USD
Million)
9.5.4.
Middle
East & Africa Resuscitation Devices Market, By Country, 2018-2029 (USD
Million)
9.5.5. UAE
9.5.5.1. UAE
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.5.5.2. UAE
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.5.5.3. UAE
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.5.6. Saudi Arabia
9.5.6.1. Saudi
Arabia Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.5.6.2. Saudi
Arabia Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.5.6.3. Saudi
Arabia Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.5.7. South Africa
9.5.7.1. South
Africa Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.5.7.2. South
Africa Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.5.7.3. South
Africa Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.5.8. Rest of Middle East & Africa
9.5.8.1. Rest
of Middle East & Africa Resuscitation Devices Market, By Product Type, 2018-2029
(USD Million)
9.5.8.2. Rest
of Middle East & Africa Resuscitation Devices Market, By Patient Type, 2018-2029
(USD Million)
9.5.8.3. Rest
of Middle East & Africa Resuscitation Devices Market, By End User, 2018-2029
(USD Million)
9.6.
Latin America
9.6.1.
Latin
America Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.6.2.
Latin
America Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.6.3.
Latin
America Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.6.4.
Latin
America Resuscitation Devices Market, By Country, 2018-2029 (USD Million)
9.6.5. Brazil
9.6.5.1. Brazil
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.6.5.2. Brazil
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.6.5.3. Brazil
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.6.6. Mexico
9.6.6.1. Mexico
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.6.6.2. Mexico
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.6.6.3. Mexico
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.6.7. Argentina
9.6.7.1. Argentina
Resuscitation Devices Market, By Product Type, 2018-2029 (USD Million)
9.6.7.2. Argentina
Resuscitation Devices Market, By Patient Type, 2018-2029 (USD Million)
9.6.7.3. Argentina
Resuscitation Devices Market, By End User, 2018-2029 (USD Million)
9.6.8. Rest of Latin America
9.6.8.1. Rest
of Latin America Resuscitation Devices Market, By Product Type, 2018-2029 (USD
Million)
9.6.8.2. Rest
of Latin America Resuscitation Devices Market, By Patient Type, 2018-2029 (USD
Million)
9.6.8.3. Rest
of Latin America Resuscitation Devices Market, By End User, 2018-2029 (USD
Million)
Chapter 10. Competitive Landscape
10.1. Market Revenue Share by Manufacturers
10.2. Competitor’s Positioning
10.3. Strategy Benchmarking
10.3.1. Partnership & Agreement
10.3.2. New Product Development
10.3.3. Mergers & Acquisitions
10.3.4. Investment & Expansion
10.4. Vendor Landscape
10.4.1. Distributors
10.4.2. North America
10.4.3. Europe
10.4.4. Asia Pacific
10.4.5. Middle East & Africa
10.4.6. Latin America
10.4.7. Others
Chapter 11. Company
Profiles
11.1. 3M
Company
11.1.1. Company Overview
11.1.2. Products Offered
11.1.3. Financials
11.1.4. Recent Development
11.1.5. Zettabyte Analytics Insights
11.2. Ambu
11.2.1. Company Overview
11.2.2. Products Offered
11.2.3. Financials
11.2.4. Recent Development
11.2.5. Zettabyte Analytics Insights
11.3. Cardinal
Health
11.3.1. Company Overview
11.3.2. Products Offered
11.3.3. Financials
11.3.4. Recent Development
11.3.5. Zettabyte Analytics Insights
11.4. Drägerwerk
Ag & Co. KGaA
11.4.1. Company Overview
11.4.2. Products Offered
11.4.3. Financials
11.4.4. Recent Development
11.4.5. Zettabyte Analytics Insights
11.5. Flexicare
11.5.1. Company Overview
11.5.2. Products Offered
11.5.3. Financials
11.5.4. Recent Development
11.5.5. Zettabyte Analytics Insights
11.6. GE
Healthcare
11.6.1. Company Overview
11.6.2. Products Offered
11.6.3. Financials
11.6.4. Recent Development
11.6.5. Zettabyte Analytics Insights
11.7. Intersurgical
11.7.1. Company Overview
11.7.2. Products Offered
11.7.3. Financials
11.7.4. Recent Development
11.7.5. Zettabyte Analytics Insights
11.8. KARL
STORZ
11.8.1. Company Overview
11.8.2. Products Offered
11.8.3. Financials
11.8.4. Recent Development
11.8.5. Zettabyte Analytics Insights
11.9. Koninklijke
Philips N.V.
11.9.1. Company Overview
11.9.2. Products Offered
11.9.3. Financials
11.9.4. Recent Development
11.9.5. Zettabyte Analytics Insights
11.10.
Medtronic Plc
11.10.1.
Company
Overview
11.10.2.
Products
Offered
11.10.3.
Financials
11.10.4.
Recent
Development
11.10.5.
Zettabyte
Analytics Insights
11.11.
Mindray Medical
11.11.1.
Company
Overview
11.11.2.
Products
Offered
11.11.3.
Financials
11.11.4.
Recent
Development
11.11.5.
Zettabyte
Analytics Insights
11.12.
Nihon Kohden
11.12.1.
Company
Overview
11.12.2.
Products
Offered
11.12.3.
Financials
11.12.4.
Recent
Development
11.12.5.
Zettabyte
Analytics Insights
11.13.
Physio-Control (A Part of Stryker Corporation)
11.13.1.
Company
Overview
11.13.2.
Products
Offered
11.13.3.
Financials
11.13.4.
Recent
Development
11.13.5.
Zettabyte
Analytics Insights
11.14.
Resmed, Inc.
11.14.1.
Company
Overview
11.14.2.
Products
Offered
11.14.3.
Financials
11.14.4.
Recent
Development
11.14.5.
Zettabyte
Analytics Insights
11.15.
Salter Labs
11.15.1.
Company
Overview
11.15.2.
Products
Offered
11.15.3.
Financials
11.15.4.
Recent
Development
11.15.5.
Zettabyte
Analytics Insights
11.16.
Smiths Medical (A Division of Smiths Group Plc)
11.16.1.
Company
Overview
11.16.2.
Products
Offered
11.16.3.
Financials
11.16.4.
Recent
Development
11.16.5.
Zettabyte
Analytics Insights
11.17.
Teleflex
11.17.1.
Company
Overview
11.17.2.
Products
Offered
11.17.3.
Financials
11.17.4.
Recent
Development
11.17.5.
Zettabyte
Analytics Insights
11.18.
Verathon (A Part of Roper Technologies)
11.18.1.
Company
Overview
11.18.2.
Products
Offered
11.18.3.
Financials
11.18.4.
Recent
Development
11.18.5.
Zettabyte
Analytics Insights
11.19.
Vyaire Medical
11.19.1.
Company
Overview
11.19.2.
Products
Offered
11.19.3.
Financials
11.19.4.
Recent
Development
11.19.5.
Zettabyte
Analytics Insights
11.20.
Zoll Medical (A Part of Asahi Kasei)
11.20.1.
Company
Overview
11.20.2.
Products
Offered
11.20.3.
Financials
11.20.4.
Recent
Development
11.20.5.
Zettabyte
Analytics Insights
Chapter 12. Appendix
12.1. Discussion guide
12.2. Knowledge Store:
Zettabyte Analytics Subscription Portal
12.3. Available Customizations
12.4. Associated Zettabyte
Analytics Reports